InvestorsHub Logo

HGilS

08/03/22 8:09 AM

#371985 RE: jour_trader #371983

These are GREAT NEWS - thanks @JT

The ELTP King

08/03/22 8:42 AM

#371987 RE: jour_trader #371983

********* ADDERALL DEMAND AT ALL-TIME HIGHS **********

It's about to get REAL.

The ELTP King

08/03/22 8:50 AM

#371988 RE: jour_trader #371983

********** Lannett is the 2nd biggest seller of Adderall only behind Teva **********

My goodness...

The ELTP King

08/03/22 8:57 AM

#371989 RE: jour_trader #371983

LOSER - Teva: "The problems are associated with packaging capacity constraints.”

WINNER - Nasrat: "We upgraded the packaging line. We have increased the capacity by 25%."

mrwrn2010

08/03/22 9:50 AM

#371991 RE: jour_trader #371983

Lannett’s Adderall market share is impressive, given that at least Teva, Mallinckrodt, Novartis and Takeda are massive, multi-billion-in-revenue companies.

Shortage for Teva means potentially more market share opportunity for Lannett/us. Good news.

imanjen13

08/09/22 12:53 PM

#372152 RE: jour_trader #371983

$276 million in Adderall sales in 2021 by Lannett. If they walk away, Elite can hire its own sales reps and talk to the pharmacies about continuing the purchases. Instead of 30 million in revenues, Elite can have a multiple above that. Hmm

Teva purchase of Elite is possible. Nice synergy.